Stock BLAU3 BLAU FARMACÊUTICA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

All News Blau Farmacêutica S.A.

Equities

BLAU3

BRBLAUACNOR8

Market Closed - Sao Paulo
Other stock markets
 21:07:00 31/05/2024 BST 		5-day change 1st Jan Change
10.26 BRL -0.74% Intraday chart for Blau Farmacêutica S.A. -2.01% -37.48%
05-08 Transcript : Blau Farmacêutica S.A., Q1 2024 Earnings Call, May 08, 2024
05-07 Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Blau Farmacêutica S.A., Q1 2024 Earnings Call, May 08, 2024
Blau Farmacêutica S A : Reunião da Administração
PU
Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : Blau Farmacêutica S.A., Q4 2023 Earnings Call, Mar 20, 2024
Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Blau Farmacêutica S.A., Q3 2023 Earnings Call, Nov 09, 2023
Blau Farmacêutica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Transcript : Blau Farmacêutica S.A., Q2 2023 Earnings Call, Aug 10, 2023
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Blau Farmacêutica S.A. completed the acquisition of Laboratorio Quimico Farmaceutico Bergamo Ltda from Amgen Inc. for $33.2 million.
CI
Transcript : Blau Farmacêutica S.A., Q1 2023 Earnings Call, May 05, 2023
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
CI
Blau Farmacêutica S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Similis Bio And Blau Farmaceutica Enter Into Development And License Agreement For Biosimilars
AQ
Tranche Update on Blau Farmacêutica S.A.'s Equity Buyback Plan announced on June 14, 2022.
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Blau Farmacêutica S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLAU3 Stock
  4. News Blau Farmacêutica S.A.